Venlafaxine Tablet, Extended Release
Product Images NDC 67877-727

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine (NDC 67877-727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Venla-150mg-90s-tablets (Venla 150mg 90s Tablets)

Venla-150mg-90s-tablets (Venla 150mg 90s Tablets)
This is a product label for Venlafaxine Extended-Release Tablets, which contain Venafaine Hydrochloride. The usual dosage is once daily, and the package provides further dosage information. The tablets should be stored at room temperature and protected from moisture and humidity. They have been manufactured by Akem Laboratories in Mumbai, India, and are distributed by Booend Laboratories. The label contains a National Drug Code (NDC) and a pharmacy message to dispense with medication guide separately to each patient. The remaining text is not readable.*
FDA Label Image

Venla-225mg-30s Tablets (Venla 225mg 30s Tablets)

Venla-225mg-30s Tablets (Venla 225mg 30s Tablets)
This is a description of venlafaxine hydrochloride in extended-release tablet form. The tablets come in different strengths (ranging from 1 to 225 mg) as indicated by the NDC number. They should be taken once daily according to the dosage information provided in the package insert. The tablets should be stored between 20°C to 25°C, with excursions permitted between 15°C and 30°C. The medication guide should be provided to each patient along with the drug label. The tablets should be protected from moisture and humidity. The drug is manufactured by Alkem Laboratories Ltd. and distributed by Ascend Laboratories, LLC.*
FDA Label Image

37'5 mg 30 Counts Container Label (Venla 37 5mg 30 Tablet)

37'5 mg 30 Counts Container Label (Venla 37 5mg 30 Tablet)
This is a description for Venlafaxine Hydrochloride extended-release tablets manufactured by Alkem Laboratories Ltd. It is recommended to take one tablet per day with the dosage information available in the package insert. The tablets are available in a 30-tablet pack size under the NDC 67877-726-30. The medication should be stored between 20°C to 25°C, with permission for excursions between 15°C and 30°C. The medication guide should be dispensed separately to each patient by the pharmacist. It is distributed by Ascend Laboratories, LLC and for prescription use only.*
FDA Label Image

Venla-75mg-90s Tablets (Venla 75mg 90s Tablets)

Venla-75mg-90s Tablets (Venla 75mg 90s Tablets)
This is a medication description for Venlafaxine Hydrochloride Extended-Release Tablets. The tablets are manufactured by Alkem Laboratories Ltd in India and distributed by Ascend Laboratories in New Jersey. Each tablet contains 75mg of Venlafaxine Hydrochloride and is meant to be taken once daily. The medication should be stored at room temperature and protected from moisture and humidity. Dosage information can be found in the Venlafaxine package insert.*
FDA Label Image

Venlahcl-str (Venlahcl Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.